Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Loading articles...

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.

Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Tag

#Aligos Therapeutics (ALGS)

2 articles found with this tag

Showing 1 to 2 of 2 articles

Aligos Therapeutics is on the Way to Treating MASH and More

Aligos Therapeutics On September 20, 2024, we posted a press release stating that Aligos Therapeutics ( ALGS ) announced successful topline results from a phase 2A HERALD study of ALG-055009, a thyroi...

Prohost Biotech

Oct 16, 2024

Aligos Therapeutics Announces Positive Topline Results from Phase 2A Herald Study of ALG-055009 for the Treatment of MASH

Aligos Therapeutics in the NEWS Yesterday, Sept. 19, 2024, Aligos Therapeutics ( ALGS ) - a small clinical-stage company, announced positive topline results from the Phase 2a HERALD study of ALG-05500...

Prohost Biotech

Sep 20, 2024

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.